Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies
International Journal of Molecular Sciences · 2023-05-23 · 24 (11) · 9167
DOI: 10.3390/ijms24119167 ↗At a glance
Journal article in International Journal of Molecular Sciences, published online on 2023-05-23. Written by Joana Jorge and 5 co-authors. Institution: Laboratory of Oncobiology and Hematology (LOH), University Clinic of Hematology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra,…. Major MEDLINE topics: Sesquiterpenes, Lymphoma. Cited 34 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY 4.0). Funded by: Fundação para a Ciência e Tecnologia, CIMAGO—Center of Investigation on Environment, Genetics and Oncobiology, Faculty of Medicine, University of Coimbra, Portugal, Foundation for Science and Technology (FCT), Portugal.
Abstract (original language)
Lymphoid malignancies are a group of highly heterogeneous diseases frequently associated with constitutive activation of the nuclear factor kappa B (NF-κB) signaling pathway. Parthenolide is a natural compound used to treat migraines and arthritis and found to act as a potent NF-κB signaling inhibitor. This study evaluated in vitro parthenolide efficacy in lymphoid neoplasms. We assessed parthenolide metabolic activity in NCI-H929 (MM), Farage (GCB-DLBCL), Raji (BL), 697 and KOPN-8 (B-ALL), and CEM and MOLT-4 (T-ALL), by resazurin assay. Cell death, cell cycle, mitochondrial membrane potential (ΔΨmit), reactive oxygen species (ROS) and reduced glutathione (GSH) levels, activated caspase-3, FAS-ligand, and phosphorylated NF-κB p65 were evaluated using flow cytometry. CMYC, TP53, GPX1, and TXRND1 expression levels were assessed using qPCR. Our results showed that parthenolide promoted a metabolic activity decrease in all cell lines in a time-, dose-, and cell-line-dependent manner. The mechanism induced by parthenolide was demonstrated to be cell line dependent. Nonetheless, parthenolide promoted cell death by apoptosis with significant ROS increase (peroxides and superoxide anion) and GSH decrease combined with a ΔΨmit reduction across all studied cell lines. Despite the need to further understand parthenolide mechanisms, parthenolide should be considered as a possible new therapeutic approach for B- and T-lymphoid malignancies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Laboratory of Oncobiology and Hematology (LOH), University Clinic of Hematology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.
- Coimbra Institute for Clinical and Biomedical Research (iCBR)-Group of Environmental Genetics of Oncobiology (CIMAGO), FMUC, University of Coimbra, 3000-548 Coimbra, Portugal.
- Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.
- Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.
- Hematology Service, Centro Hospitalar e Universitário de Coimbra (CHUC), 3000-061 Coimbra, Portugal.
ORCID profiles: Joana Jorge, Joana Neves, Raquel Alves, Ana Cristina Gonçalves, Ana Bela Sarmento-Ribeiro
Funding
- Fundação para a Ciência e Tecnologia
- CIMAGO—Center of Investigation on Environment, Genetics and Oncobiology, Faculty of Medicine, University of Coimbra, Portugal
- Foundation for Science and Technology (FCT), Portugal
- COMPETE-FEDER
Cite
APA
Jorge, J., Neves, J., Alves, R., Geraldes, C., Gonçalves, A. C., & Sarmento-Ribeiro, A. B. (2023). Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies. International Journal of Molecular Sciences, 24(11), 9167. https://doi.org/10.3390/ijms24119167
Vancouver
Jorge J, Neves J, Alves R, Geraldes C, Gonçalves AC, Sarmento-Ribeiro AB. Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies. International Journal of Molecular Sciences. 2023;24(11):9167. doi:10.3390/ijms24119167
BibTeX
@article{Jorge2023,
author = {Jorge, Joana and Neves, Joana and Alves, Raquel and Geraldes, Catarina and Gonçalves, Ana Cristina and Sarmento-Ribeiro, Ana Bela},
title = {Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {11},
pages = {9167},
doi = {10.3390/ijms24119167}
}
EUVIMED